Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Genetics Named Service Provider for Roche NimbleGen Target-Enrichment Tech

Premium

Roche NimbleGen said today that genomic services provider Ambry Genetics has become a certified service provider for the NimbleGen SeqCap EZ Exome workflow.

Ambry, based in Aliso Viejo, Calif., will provide target enrichment services using SeqCap EZ Human Exome combined with next-generation sequencing services.

The SeqCap EZ Exome technology uses a single tube of stable DNA oligos to capture all exons in solution in a simple, scalable workflow, and contains 2.1 million empirically optimized DNA probes, according to Roche NimbleGen.

Under the partnership, Ambry will process customer genomic DNA samples for enrichment using SeqCap to capture all human coding exons, and sequence the enriched samples using short-read, paired-end sequencing, Roche NimbleGen said.

Ambry becomes Roche NimbleGen's first service provider in the US, the companies said.

Roche NimbleGen CEO Frank Pitzer said in a statement that Ambry's genomics and next-gen sequencing services were "an ideal fit" with the SeqCap EZ Exome technology, and that the partnership will provide more researchers with access to the technology.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.